Coming to "Grp(s)" with Senescence in the Alveolar Epithelium.
Coming to "Grp(s)" with Senescence in the Alveolar Epithelium.
复制标题
来到“Grp(s)”,肺泡上皮细胞衰老。
DOI:
10.1164/rccm.201910-2052ed
复制
发表时间:
2020
影响因子:
24.7
通讯作者:
Kropski,JonathanA
中科院分区:
文献类型:
--
作者:
Winters,NichelleI;Kropski,JonathanA
7. Taylor-Cousar JL, Jain M, Barto TL, Haddad T, Atkinson J, Tian S, et al.; VX14-809-106 Investigator Group. Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR. J Cyst Fibros 2018; 17: 228-235. 8. Hubert D, Chiron R, Camara B, Grenet D, Prévotat A, Bassinet L, et al. Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease. J Cyst Fibros 2017; 16: 388-391. 9. Jennings MT, Dezube R, Paranjape S, West NE, Hong G, Braun A, et al. An observational study of outcomes and tolerances in patients with cystic fibrosis initiated on lumacaftor/ivacaftor. Ann Am Thorac Soc 2017; 14: 1662-1666.